Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. - Wikidata - awgldk - TriplyDB

Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.

Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.

http://www.wikidata.org/entity/Q34420980

about

P1343

STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors EPLIN, epithelial protein lost in neoplasm A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4 Androgen receptor molecular biology and potential targets in prostate cancer Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2 The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle Transcriptional programs activated by exposure of human prostate cancer cells to androgen Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy Heat-shock factor 2 is a suppressor of prostate cancer invasion.Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6 Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer.Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2 20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor.Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer Efficacy of c-Met inhibitor for advanced prostate cancer.Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines The gender of cell lines matters when screening for novel anti-cancer drugs.17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo.

P2860

Q29565860-9880CE6E-22E0-4E89-9A00-C63A235828CA Q54901925-63EB4DEE-317C-48DA-89AF-4C3CCFCBE839

P1343

Q22010908-DCC3367A-00F6-41E9-B94B-C1D15D612A8E Q22011008-9FEF8E99-C038-4FEF-8C72-D43251912794 Q24304373-BF616B24-EC19-4BF6-9647-E3C4844407E8 Q24602861-70E1A662-0402-4227-9F95-907FD15350D0 Q24614665-D42360FD-4066-471B-8278-46F0CCA0542B Q24625643-5F715D6D-54CE-45E2-A2A9-9EC38B43ECDA Q24655583-C30B0451-2586-48AE-9F87-12FB882825B7 Q24669875-313451B9-7BBC-4891-98E5-34CF9194DE02 Q24673693-A2E70FB1-704C-44F4-BB9B-141358DE8B07 Q24685731-A701E348-7F1C-4089-B316-DF4728E6A7DA Q24685775-3947FCC8-5FE8-4DF3-A030-AE510620100B Q24802648-2EC9C9CB-5668-4BF1-9217-E549D2B7D020 Q26777310-94D60C8E-FE6B-4DE7-B414-9BEFBF778DC7 Q26800877-A81AED2F-C127-4B03-A31E-81DC1621A9BA Q27309985-40A29F80-F878-4D3C-B4D8-79CB246FC407 Q28208123-252E34DD-7D0A-4880-9A3D-E199F6DDBE27 Q28301664-CF3CAF00-6724-4B48-95C3-34B249184D61 Q28478630-797EE684-512C-46AE-9573-A274BBCB499C Q28534575-AAAD1083-7B9C-4274-887E-559FC11E5999 Q30433918-3669DDD3-8EB7-4C5F-9D28-20F0A6116896 Q30434948-396FAEFF-D83D-4B80-A85B-78C3533BF6FD Q30472489-C534100E-CF87-4308-A3B5-53DDB5150276 Q30492895-6C0772C0-DA3B-4A47-AE86-6CEA7F302076 Q30500080-B35E1A72-A855-4E04-B164-CB2F92EFD15A Q30504566-7C72640D-4E98-4A4F-894E-5A06D72FA1ED Q30523968-B5C9C0A3-73C3-43EF-8EE3-D525A7E286DD Q30528764-015039DE-419A-4DFF-A473-0AB6F0BDE3DC Q33565805-94C1BF80-6501-4713-B75A-E581F2F74AA4 Q33647321-570AAA1A-737C-4519-A96F-0F60EE6AE8AB Q33650205-9A9C0F70-83A4-48C9-87EB-0CBF5670C125 Q33718726-3F32995F-0ECE-4D99-A4FD-5604EB095520 Q33766326-651FD640-E91E-4024-BFEE-D9DD1CA916DE Q33803985-668CA4A5-D533-4F21-A650-755C89A08829 Q33821586-C4F7A913-BABA-4DD3-B98D-D4E30DBFA3D6 Q33896008-57C35F87-FFFD-4D22-A83D-0EB4662BE69B Q33981807-78AD4262-7F1B-4A35-A220-BDB2A54E14BB Q34012237-D2547324-70F2-4E57-9FAC-A6E2F236300C Q34090944-F36198A3-4E7F-4D1F-ABB0-47120AF82D21 Q34126555-71EC1626-BAE6-42D8-A220-759D6A688F99 Q34233801-EDD27BE3-11A7-4838-9699-D3B4AD4EAD7B

P2860

Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.

http://www.wikidata.org/entity/Q34420980

description

1997 nî lūn-bûn

@nan

1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Progression of metastatic huma ...... in immunodeficient SCID mice.

@ast

Progression of metastatic huma ...... in immunodeficient SCID mice.

@en

Progression of metastatic huma ...... in immunodeficient SCID mice.

@nl

type

label

Progression of metastatic huma ...... in immunodeficient SCID mice.

@ast

Progression of metastatic huma ...... in immunodeficient SCID mice.

@en

Progression of metastatic huma ...... in immunodeficient SCID mice.

@nl

prefLabel

Progression of metastatic huma ...... in immunodeficient SCID mice.

@ast

Progression of metastatic huma ...... in immunodeficient SCID mice.

@en

Progression of metastatic huma ...... in immunodeficient SCID mice.

@nl

P1433

Q34420980-2B17D6DF-FD70-4B3F-9FB5-0C296DA004B5

P1476

Q34420980-0E1E6BB6-7ADA-4FF5-A559-213938A7335B

P2093

Q34420980-05ED7D1F-D086-4990-BB7E-1D259D2B0D98

Q34420980-2CAA9322-F410-4A2C-9884-96F0FD1D1EC7

Q34420980-2CBBA376-2F45-41CC-9F31-4531852A18B9

Q34420980-500F18B8-411D-49A9-9A4A-98E8CB0F93C9

Q34420980-5820BB20-DD55-4E31-BA58-EA6E6DB913CA

Q34420980-5A41D0EB-EF57-4933-A3CE-8BB402C0D4F8

Q34420980-6292A72B-BED1-4D1F-8304-CF93972C86BA

Q34420980-6EDD9A2A-68EE-4285-A256-BFBA4180746D

Q34420980-816111C6-AF9D-4633-B307-E097C7986550

Q34420980-C38F07D4-D655-4AE0-AFC1-DD65459E9FBF

P2860

Q34420980-1CE3A738-7EAB-4E59-A7B6-26A7D6D2C50D

Q34420980-309A403C-54B5-48AB-9C25-37D8A3B01117

Q34420980-3BC0BC07-EF5E-4841-B5AB-0BF8A4C8D254

Q34420980-46CFFE77-ECF2-4F94-B2C6-EA7BFE6EF6DE

Q34420980-4958E6C0-4EFA-466C-AB10-DB9713529ED9

Q34420980-7619DB24-892D-4374-A1B4-BA872EBEDEF5

Q34420980-8A3E3119-37D4-4E4C-BF2A-BBCA949DBC0E

Q34420980-C5FCA18A-DB7F-42FD-AB9D-F23CED322EA9

Q34420980-F6931A2C-66EA-4CE4-8A6C-1FE273E39E87

P2888

Q34420980-1029EE2D-E59B-4DD4-A98F-98641632FC92

P304

Q34420980-DBAEFDA1-1DAD-4AEF-BFF5-7F0481541DA2

P31

Q34420980-7F81EA8E-CB99-4D5B-BD4C-FF32C1BBAD25

P356

Q34420980-BBD35006-BDF2-40ED-BBF8-A5AFE6FEBF01

P407

Q34420980-2E82FF07-C358-4589-B85C-330E8E38E87F

P433

Q34420980-5999D1B7-7FFC-472A-9303-ECB842B2F28E

P4510

Q34420980-048AD906-6300-4FF3-ACEF-A3615D72FC99

Q34420980-C493F9F4-5B46-4573-B499-B0EED5E148F0

P478

Q34420980-F2E17054-7277-49B4-BC30-5F3C9C443A2F

P577

Q34420980-B70E2A2E-887F-40C8-A311-54E3EC0EEB8F

P698

Q34420980-15264A2B-DD0C-4BFB-A389-EA30F6C3CE61

P921

Q34420980-5729B6E9-F5FA-462A-A242-262771E87861

P356

P1433

Nature Medicine

P1476

Progression of metastatic huma ...... in immunodeficient SCID mice.

@en

P2093

Belldegrun A

http://www.w3.org/2001/XMLSchema#string

Brothman AR

http://www.w3.org/2001/XMLSchema#string

Klein KA

http://www.w3.org/2001/XMLSchema#string

Lamb DJ

http://www.w3.org/2001/XMLSchema#string

Marcelli M

http://www.w3.org/2001/XMLSchema#string

Moradi H

http://www.w3.org/2001/XMLSchema#string

Redula J

http://www.w3.org/2001/XMLSchema#string

Reiter RE

http://www.w3.org/2001/XMLSchema#string

Sawyers CL

http://www.w3.org/2001/XMLSchema#string

Witte ON

http://www.w3.org/2001/XMLSchema#string

P2860

Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay.

Androgen receptor mutations.

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.

Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid.

The SCID-hu mouse as a model for HIV-1 infection.

Basement membrane components (matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen.

Frequent development of murine T-cell lymphomas with TcR alpha/beta+, CD4-/8- phenotype after implantation of human inflammatory breast cancer cells in BALB/c nude mice.

P2888

P304

402-408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM0497-402

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P4510

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

1997-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9095173

http://www.w3.org/2001/XMLSchema#string

P921